NAION Permanent Blindness & Ozempic Eye Injury Lawsuits in Ohio — Attorney911 Pursues Novo Nordisk for Failure to Warn of Optic Nerve Ischemia, Ralph Manginello’s 27+ Years of Federal-Court Trial Practice in Complex Products Liability, We Litigate Semaglutide Risks Following the Morris Lawsuit and Emerging Clinical Evidence, Lupe Peña the Former Insurance-Defense Insider Who Knows How Pharmaceutical Companies Shield Safety Data, Millions Recovered for Catastrophic Injuries, We Secure OCT Imaging and Pharmacy Records Before the Preservation Window Closes — Free 24/7 Consultation, No Fee Unless We Win, Hablamos Español, 1-888-ATTY-911
Ohio Ozempic Vision Loss Lawsuits: Proving NAION Claims Against Novo Nordisk Sudden darkness does not arrive with a warning. For many Ohio residents, the use of semaglutide medications like Ozempic and Wegovy has ended in a devastating diagnosis: Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION). This is not a simple case of blurry vision that a new prescription can fix. This is an irreversible “stroke of the eye” that results in permanent partial or complete blindness. If you are facing this crisis, you are not just a medical statistic. You are a victim of what we examine as a massive failure by a multi-billion dollar drug manufacturer to prioritize patient safety over marketing success. At Attorney911, we believe that when a company like Novo Nordisk knows—or should know—that their product can cause permanent blindness, they have a legal and moral duty to tell the truth to every doctor and patient in Ohio. Understanding the Link Between Semaglutide and NAION The medical community has begun to sound the alarm on a disturbing connection between semaglutide (the active ingredient in Ozempic and Wegovy) and NAION. While these drugs were originally designed to treat Type 2 diabetes, their surge in popularity for weight loss…